Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
46,710,940
-
Share change
-
+1,637,080
-
Total reported value
-
$2,484,615,288
-
Put/Call ratio
-
195%
-
Price per share
-
$53.19
-
Number of holders
-
250
-
Value change
-
+$82,301,484
-
Number of buys
-
126
-
Number of sells
-
104
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2022
As of 30 Sep 2022 Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) had 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,710,940 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, BAILLIE GIFFORD & CO, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ARMISTICE CAPITAL, LLC, LOOMIS SAYLES & CO L P, Spyglass Capital Management LLC, Stephens Investment Management Group LLC, and Invesco Ltd..
This table shows 254 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.